Arcoma

Arcoma Operating Expenses

The Total Operating Expenses of Arcoma (ARCOMA.ST) as of Oct 23, 2026 is 33.54 M SEK. In the previous year, Total Operating Expenses was 34.60 M SEK — a change of -3.06% (lower).

Operating Expenses

33.54 MSEK

YoY

-3.06%

Last updated:

Total Operating Expenses of Arcoma is 2024 33.54 M SEK. Total Operating Expenses of Arcoma was 2023 34.60 M SEK. It decreases by -3.06% lower compared to the previous year.

The Arcoma Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2017
19.83 M SEK
Jan 1, 2018
20.39 M SEK
Jan 1, 2019
19.61 M SEK
Jan 1, 2020
20.73 M SEK
Jan 1, 2021
25.69 M SEK
Jan 1, 2022
22.13 M SEK
Jan 1, 2023
34.60 M SEK
Jan 1, 2024
33.54 M SEK
The Arcoma Operating Expenses history
YEAROperating ExpensesYoY
33.54 MSEK-3.06%
34.60 MSEK+56.32%
22.13 MSEK-13.85%
25.69 MSEK+23.93%
20.73 MSEK+5.73%
19.61 MSEK-3.85%
20.39 MSEK+2.82%
19.83 MSEK+36.77%
14.50 MSEK-0.60%
14.59 MSEK+54.99%
9.41 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Total Operating Expenses of Arcoma is 33.54 M SEK in 2024.

Total Operating Expenses of Arcoma changed from 34.60 M SEK to 33.54 M SEK, representing a -3.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Arcoma since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Arcoma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Arcoma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Arcoma